Vaccine Therapy in Treating Patients With Metastatic Melanoma
Phase 1/2 Unknown
30 enrolled
Sunitinib, Tamoxifen, and Cisplatin in Treating Patients With High-Risk Ocular Melanoma
Phase 2 Unknown
50 enrolled
Sorafenib, Tamoxifen, and Cisplatin in Treating Patients With High-Risk Stage III Melanoma
Phase 2 Unknown
200 enrolled
Sorafenib, Bevacizumab, and Oxaliplatin in Treating Patients With Metastatic Malignant Melanoma
Phase 1/2 Unknown
54 enrolled
Photodynamic Therapy Using Aminolevulinic Acid in Treating Patients With Skin Cancer
Phase 2 Unknown
20 enrolled
Valproic Acid in Treating Patients With Previously Treated Non-Hodgkin Lymphoma, Hodgkin Lymphoma, or Chronic Lymphocytic Leukemia
Phase 2 Unknown
52 enrolled
Interferon Alfa With or Without Vaccine Therapy in Treating Patients With Metastatic Melanoma
Phase 3 Unknown
300 enrolled
Vaccine Therapy With or Without Interleukin-2 in Treating Patients With Stage III or Stage IV Melanoma
Phase 1/2 Unknown
36 enrolled
Combination Chemotherapy Followed by Donor Bone Marrow Transplant or Peripheral Stem Cell Transplant in Treating Patients With Hematologic Cancer or Genetic Disorders
Phase 2 Unknown
52 enrolled
Vaccine Therapy in Treating Patients Who Have Stage II, Stage III, or Stage IV Melanoma
Phase 1/2 Unknown
Oblimersen and Dacarbazine in Treating Patients With Advanced Malignant Melanoma That Has Responded to Treatment on Clinical Trial GENTA-GM301
Phase NA Unknown
Interleukin-2 in Treating Patients With Metastatic Melanoma
Phase 2 Unknown
20 enrolled
Levofloxacin Compared With Cefepime in Treating Cancer Patients With Fever and Neutropenia
Phase 3 Unknown
Vaccine Therapy in Treating Patients With Malignant Melanoma
Phase 2 Unknown
Gefitinib and PEG-Interferon Alfa-2a in Treating Patients With Unresectable or Metastatic Skin Cancer
Phase 1/2 Unknown
16 enrolled
Umbilical Cord Blood and Placental Blood Transplantation in Treating Patients With Hematologic Cancer or Aplastic Anemia
Phase 2 Unknown
30 enrolled
Vaccine Therapy in Treating Patients With Metastatic Melanoma
Phase 1 Unknown
Chemotherapy and Photodynamic Therapy in Treating Patients With Cutaneous T-Cell Lymphoma
Phase 2 Unknown
Vaccine Therapy With or Without Sargramostim in Treating Patients With High-Risk or Metastatic Melanoma
Phase 1 Unknown
Interleukin-2 With or Without Histamine Dihydrochloride in Treating Patients With Stage IV Melanoma Metastatic to the Liver
Phase 3 Unknown
Computer-Based Continuing Education for Doctors in Examination and Counseling of Patients on Skin Cancer or Weight Control
Phase NA Unknown
4,550 enrolled
Bioelectric Field Imaging in Diagnosing Melanoma and Other Skin Cancers in Patients With Skin Lesions
Phase 1 Unknown
100 enrolled
Emergency Use of Donor Lymphocytes in Treating Patients Who Have Undergone Donor Stem Cell Transplant and Have Cytomegalovirus Infections
Phase 1 Unknown
20 enrolled
T4N5 Liposome Lotion Compared With Placebo Lotion for Preventing Actinic Keratoses in Patients With Xeroderma Pigmentosum
Phase 3 Unknown
30 enrolled
Arsenic Trioxide in Treating Patients With Recurrent or Refractory Acute Leukemia, Chronic Myeloide Leukemia, Myelodysplasia, Lymphoma, or Myeloma
Phase 2 Unknown
60 enrolled
Carboplatin and Temozolomide in Treating Patients With Unresectable or Metastatic Melanoma
Phase 1 Unknown
30 enrolled
Biological Therapy and Temozolomide in Treating Patients With Metastatic Melanoma
Phase 1 Unknown
18 enrolled
Carbendazim in Treating Patients With Advanced Solid Tumors or Lymphoma
Phase 1 Unknown
Boron Neutron Capture Therapy in Treating Patients With Stage III Melanoma
Phase 1 Unknown
15 enrolled
Bleomycin With or Without Electroporation Therapy in Treating Patients With Stage III or Stage IV Melanoma
Phase 1 Unknown
Vaccine Therapy in Treating Patients With Metastatic Melanoma
Phase 1 Unknown
Vaccine Therapy in Treating Patients With Stage IV Melanoma
Phase 1/2 Unknown
30 enrolled
AMG 706 and Gemcitabine in Treating Patients With Advanced Solid Tumors or Lymphoma
Phase 1 Unknown
18 enrolled
Study of Genes and Environment in Patients With Cancer in East Anglia, Trent, or West Midlands Regions of the United Kingdom
Unknown
14,000 enrolled
Comparing Follow-Up Schedules in Patients With Newly Diagnosed Stage IB or Stage II Melanoma
Unknown
178 enrolled
Melanoma Vaccine in Treating Patients With Stage III Melanoma After Surgery to Remove Lymph Nodes
Phase 1/2 Unknown
22 enrolled
Temozolomide and Bevacizumab in Treating Patients With Metastatic Melanoma of the Eye
Phase 2 Unknown
35 enrolled
Early Hospital Discharge or Standard Inpatient Care in Cancer Patients Receiving Antibiotics for Febrile Neutropenia
Phase 3 Unknown
400 enrolled
Study of Families With Melanoma
Unknown
3,700 enrolled
External-Beam Radiation Therapy With or Without Indinavir and Ritonavir in Treating Patients With Brain Metastases
Phase 2 Unknown
60 enrolled
Answering Questions About Vitamin D Supplementation and Sun Exposure in Patients Who Have Undergone Surgery for Stage IB, Stage II, or Stage IIIA Melanoma
Unknown
2,774 enrolled
Studying Tumor Tissue Samples From Patients With Melanoma Who Have Undergone Sentinel Lymph Node Biopsy
Unknown
1,000 enrolled
Study of Information Received About Fertility and Infertility in Patients Who Have Finished Treatment for Cancer
Unknown
96 enrolled
Immunotherapy After Surgery in Treating Patients With Breast Cancer, Colon Cancer, or Melanoma
Phase 3 Unknown
High-Dose or Low-Dose Interferon Alfa Compared With No Further Therapy Following Surgery in Treating Patients With Stage III Melanoma
Phase 3 Unknown
1,000 enrolled
Ketamine Hydrochloride and Best Pain Management in Treating Cancer Patients With Neuropathic Pain
Phase 3 Unknown
214 enrolled
Sorafenib and Temozolomide in Treating Patients With Stage III or Stage IV Melanoma
Phase 1/2 Unknown
58 enrolled
Stem Cell Transplant in Treating Patients With Hematological Cancer or Other Disorders
Phase 2 Unknown
50 enrolled
Combination Chemotherapy in Treating Patients With Relapsed or Refractory Aggressive Non-Hodgkin's Lymphoma
Phase 1 Unknown
Vaccine Therapy in Treating Patients With Stage III or Stage IV Melanoma
Phase 2 Unknown
40 enrolled